Published 13.19
Two and a half years after a 200-second review of Svea’s vaccine, it turns out that the vaccine giant has continued with too-warm refrigerators and dirty work clothes.
– The shortcomings are very serious and then it is problematic that IVO has had very long processing times, says Health Care Minister Elisabet Lann (KD).
Svea vaccine – it has happened
Elizabeth Lann says that what emerged about Swelling vaccine is “incredibly serious”:
– It’s terrible. All kinds of shortcomings of this kind in care are incredibly deplorable and you shouldn’t have to experience it.
But why is it that you don’t stop an activity immediately when you see that it could pose a danger to those who go and get vaccinated?
– IVO first demands answers to what they see. Then they can issue an injunction with or without a fine. After that, they can also shut down the business. But sometimes a report does not lead to criticism or a fine, or the report is simply unwarranted. Therefore, we need to have legal certainty in the system, so that we do not shut down businesses unnecessarily. This is a balancing act that Ivo needs to manage all the time.
But here it is not a matter of having behaved or having changed the problems, but here it has had to continue. What should you as the responsible minister do now that you know this?
– As a minister, it would be extremely inappropriate if I said how an authority should act in a specific case. This is why I return to the fact that Ivo must continue to work on shortening his processing times so that patients are not exposed to unnecessary danger.
Do you think it is reasonable that Svea vaccine is allowed to be open today and in the future when it could pose a danger to patient safety?
– We must never have operations that pose a danger to patient operations. But as a minister, I cannot step in and review the actions of an authority in a particular case.
But you can propose changes to the authority’s mission.
– We do things there all the time. IVO has been given a very much expanded mission. They have received larger grants, 100 million extra this year alone to strengthen the work and even more in the coming years. We constantly try to develop Ivo’s mission and operations to reduce the risk for the patient, says Elisabet Lann.
